Strasbourg, France

Anne-Sophie Korganow


Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2006-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Anne-Sophie Korganow: Innovator in Medical Research

Introduction

Anne-Sophie Korganow is a distinguished inventor based in Strasbourg, France. With a focus on medical innovations, she has contributed significantly to various therapeutic areas through her innovative patents. Her work highlights the advancement of treatment options in the field of autoimmune diseases and arthritic conditions.

Latest Patents

Anne-Sophie Korganow holds three notable patents, reflecting her commitment to enhancing medical treatments. Her latest inventions include:

1. **Analogues of Hydroxychloroquine (HCQ) Without Retinal Toxicity** - This invention relates to hydroxychloroquine analogues that exhibit superior activity compared to hydroxychloroquine but are free from retinal cytotoxicity. The invention not only provides a novel method of preparation but also outlines its use in treating lupus erythematosus.

2. **Use of Glucose-6-Phosphate Isomerase and Antibodies for the Diagnosis and Therapy of Arthritis** - This patent focuses on the application of antibodies targeting glucose-6-phosphate isomerase for diagnosing arthritis and utilizing this protein for its treatment. Additionally, it describes a process for isolating monoclonal antibodies that can combat arthritis, alongside methods for assessing the anti-arthritis potential of various compositions.

Career Highlights

Throughout her illustrious career, Anne-Sophie has collaborated with prestigious research institutions, most notably the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and Inoviem Scientific. Her work in these organizations has solidified her reputation as a leader in medical innovation.

Collaborations

Anne-Sophie has worked alongside respected colleagues, including Christophe O. Benoist and Isao Matsumoto. Their collaborative efforts have been instrumental in advancing research and bringing about significant contributions to the medical field.

Conclusion

Anne-Sophie Korganow is an exemplary inventor whose innovations have the potential to change the landscape of treatment for autoimmune diseases and arthritis. Her dedication to research and development underscores the importance of innovation in improving patient outcomes. As her work continues to evolve, she remains an influential figure in medical research and patent innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…